603 filings
Page 3 of 31
8-K
BPTH
Bio-Path Holdings Inc
14 Dec 23
Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia
4:05pm
DEFA14A
BPTH
Bio-Path Holdings Inc
8 Dec 23
Additional proxy soliciting materials
4:05pm
8-K
BPTH
Bio-Path Holdings Inc
8 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
BPTH
Bio-Path Holdings Inc
15 Nov 23
Bio-path Holdings Reports Third Quarter 2023 Financial Results
7:30am
10-Q
2023 Q3
BPTH
Bio-Path Holdings Inc
Quarterly report
14 Nov 23
12:00am
DEFA14A
BPTH
Bio-Path Holdings Inc
27 Oct 23
Additional proxy soliciting materials
4:35pm
DEF 14A
BPTH
Bio-Path Holdings Inc
Definitive proxy
27 Oct 23
4:30pm
8-K
BPTH
Bio-Path Holdings Inc
24 Oct 23
Regulation FD Disclosure
4:30pm
8-K
BPTH
Bio-Path Holdings Inc
15 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
BPTH
Bio-Path Holdings Inc
15 Aug 23
Bio-path Holdings Reports Second Quarter 2023 Financial Results
7:10am
10-Q
2023 Q2
BPTH
Bio-Path Holdings Inc
Quarterly report
14 Aug 23
4:10pm
8-K
BPTH
Bio-Path Holdings Inc
7 Aug 23
Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million Public Offering
4:42pm
424B3
BPTH
Bio-Path Holdings Inc
7 Aug 23
Prospectus supplement
7:21am
424B4
BPTH
Bio-Path Holdings Inc
7 Aug 23
Prospectus supplement with pricing info
7:16am
EFFECT
BPTH
Bio-Path Holdings Inc
3 Aug 23
Notice of effectiveness
12:15am
8-K
BPTH
Bio-Path Holdings Inc
1 Aug 23
Bio-Path Holdings Announces Positive Results from Interim Analysis of Phase 2 Clinical Trial of Prexigebersen in Acute Myeloid Leukemia
5:02pm
S-1/A
BPTH
Bio-Path Holdings Inc
IPO registration (amended)
1 Aug 23
4:05pm
S-1/A
BPTH
Bio-Path Holdings Inc
IPO registration (amended)
1 Aug 23
7:50am
CORRESP
BPTH
Bio-Path Holdings Inc
1 Aug 23
Correspondence with SEC
12:00am
CORRESP
BPTH
Bio-Path Holdings Inc
1 Aug 23
Correspondence with SEC
12:00am